Global Oncology Academy

Advancing Care for Men with Breast Cancer
Advancing Care for Men with Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Advancing Care for Men with Breast Cancer
- Jose Pablo Leone, MD
The Past, Present, and Future of Metastatic Breast Cancer Care
The Past, Present, and Future of Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast Cancer
The Past, Present, and Future of Metastatic Breast Cancer Care
- Ryan Quigley
- Gregory Vidal, MD, PhD
Embedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
Embedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
Clinician's Roundtable
Embedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
Risk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Risk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Clinician's Roundtable
Risk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Improving CRC Screening Uptake: An Integrated Approach
Improving CRC Screening Uptake: An Integrated Approach
Clinician's Roundtable
Improving CRC Screening Uptake: An Integrated Approach
- Mallik Greene, PhD
Closing Gaps in CRC Screening: Patient-Centered Strategies
Closing Gaps in CRC Screening: Patient-Centered Strategies
On the Frontlines of Colorectal Cancer
Closing Gaps in CRC Screening: Patient-Centered Strategies
- Peter Buch, MD, FACG, AGAF, FACP
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
AudioAbstracts
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
- Ryan Quigley
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Project Oncology®
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening

Medical News

Medical News
CD3 T-Cell Engagers in Solid Tumours: Engineering, Resistance, and Translational Platforms
03/30/2026
Read more
Medical News
Microglial Fructose Metabolism and Immune Suppression in Glioblastoma
03/19/2026
Read more
Medical News
Clinical AI in Radiology: Translational Tools, Deployment, and Workflow Themes
03/16/2026
Read more
Medical News
Gut Microbiome and Checkpoint Immunotherapy: Reporting Recent Synthesis
03/11/2026
Read more

See more news

CME/CE

Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
CME/CE
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
0.25 credits
- Mariana C. Castells, MD, PhD
- Tsewang Tashi, MD
0.25 credits
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CE
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
0.25 credits
- Benjamin Levy, MD
0.25 credits
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
CME/CE
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
0.25 credits
- Charles E. Geyer Jr., MD, FACP
- Komal Jhaveri, MD, FACP
0.25 credits
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
CME/CE
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
1.00 credit
- Ryan D. Cassaday, MD
- Daniel J. DeAngelo, MD, PhD
1.00 credit

Clinical Practice

Protecting Heart Health in Metastatic Breast Cancer
Protecting Heart Health in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Protecting Heart Health in Metastatic Breast Cancer
- Ryan Quigley
- Gregory Vidal, MD, PhD
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
- Charles Turck, PharmD, BCPS, BCCCP
- Marwan G. Fakih, MD
Updates in AML Care: Evolving ASH Guidelines for Older Adults
Updates in AML Care: Evolving ASH Guidelines for Older Adults
On the Frontlines of AML/ALL
Updates in AML Care: Evolving ASH Guidelines for Older Adults
- Shelina Ramnarine, PhD
- Mikkael A. Sekeres, MD, MS
Venetoclax and Palbociclib in AML: Exploring New Findings
Venetoclax and Palbociclib in AML: Exploring New Findings
On the Frontlines of AML/ALL
Venetoclax and Palbociclib in AML: Exploring New Findings
- Ryan Quigley
- Jeffrey Tyner, PhD
- Melissa Stewart, PhD

Programs

Personalized Risk Communication and Its Effect on CRC Screening Choice
Personalized Risk Communication and Its Effect on CRC Screening Choice
Clinician's Roundtable
Personalized Risk Communication and Its Effect on CRC Screening Choice
Comparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
Comparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
AudioAbstracts
Comparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
- Ryan Quigley
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Project Oncology®
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
Project Oncology®
How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
- Alexandria May, PharmD, BCPS
- Sunnie Kim, MD